Prof Karl Hoffmann

PhD

Noder: Mae gwybodaeth ychwanegol neu manylach ar y fersiwn Saesneg o'r proffil hwn.

Grwpiau Ymchwil

Cyhoeddiadau

Padalino, G, Duggan, K, Mur, LAJ, Maillard, J-Y, Brancale, A & Hoffmann, KF 2024, 'Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms', MicrobiologyOpen, vol. 13, no. 6, e011. 10.1002/mbo3.70011
Rawat, M, Padalino, G, Yeo, T, Brancale, A, Fidock, DA, Hoffmann, KF & Lee, MCS 2024 'Quinoxaline-Based Anti-Schistosomal Compounds Have Potent Anti-Malarial Activity' bioRxiv. 10.1101/2024.04.23.590861
Padalino, G, Celatka, C, Rienhoff Jr., HY, Kalin, JH, Cole, PA, Lassalle, D, Forde-Thomas, J, Chalmers, I, Brancale, A, Grunau, C & Hoffmann, K 2023, 'Chemical modulation of Schistosoma mansoni lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changes', Wellcome Open Research, vol. 8, no. 146, 146. 10.12688/wellcomeopenres.18826.1
Chakroborty, A, Pritchard, D, Bouillon, ME, Cervi, A, Kraehenbuehl, R, Wild, C, Fenn, C, Holdsworth, PA, Capner, C, Padalino, G, Forde-Thomas, J, Payne, J, Smith, BG, Fisher, M, Lahmann, M, Baird, MS & Hoffmann, K 2023, 'Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica', Pharmaceutics, vol. 15, no. 7, 1869. 10.3390/pharmaceutics15071869
Caldwell, N, Afshar, R, Baragaña, B, Bustinduy, AL, Caffrey, CR, Collins, JJ, Fusco, D, Garba, A, Gardner, M, Gomes, M, Hoffmann, KF, Hsieh, M, Lo, NC, McNamara, CW, Nono, JK, Padalino, G, Read, KD, Roestenberg, M, Spangenberg, T, Specht, S & Gilbert, IH 2023, 'Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022', ACS Infectious Diseases, vol. 9, no. 5, pp. 1046-1055. 10.1021/acsinfecdis.3c00081
Mwy o gyhoeddiadau ar y Porth Ymchwil